Gut microbiota in coronary artery disease: a friend or foe?
Authors:
Open Access
- 15 May 2020
- journal article
- review article
- Published by Portland Press Ltd. in Bioscience Reports
- Vol. 40 (5)
Abstract
There is growing interest in the role of gut microbiota in the pathophysiology of several diseases, including coronary artery diseases (CAD). Gut microorganisms may produce beneficial effects in myocardial ischemia either directly in the form of exogenous administration or indirectly by acting on fiber-rich food to produce important cardioprotective components. The harmful effects of gut microbiota in CAD are due to alteration in their composition with a significant decrease in Bacteroidetes and an increase in Firmicutes, Escherichia, Shigella, and Enterococcus. The altered microbiota may produce potentially toxic metabolites, including trimethylamine-N-oxide (TMAO). Indeed, the fasting plasma levels of TMAO are directly correlated to increased risk of major cardiovascular events in CAD patients, and it is proposed as a potential biomarker to predict the onset of major cardiovascular events. It is concluded that the change in the composition of gut microbiota in CAD patients may predispose to more harmful effects. However, exogenous delivery of probiotics may overcome the detrimental effects of myocardial ischemia.Keywords
This publication has 82 references indexed in Scilit:
- The probiotic Lactobacillus rhamnosus BFE5264 and Lactobacillus plantarum NR74 promote cholesterol efflux and suppress inflammation in THP‐1 cellsJournal of the Science of Food and Agriculture, 2012
- Reduction in cholesterol absorption in Caco-2 cells through the down-regulation of Niemann-Pick C1-like 1 by the putative probiotic strainsLactobacillus rhamnosusBFE5264 and Lactobacillus plantarum NR74 from fermented foodsInternational Journal of Food Sciences and Nutrition, 2012
- TGR5 Activation Inhibits Atherosclerosis by Reducing Macrophage Inflammation and Lipid LoadingCell Metabolism, 2011
- Gut Microbiota in Health and DiseasePhysiological Reviews, 2010
- A human gut microbial gene catalogue established by metagenomic sequencingNature, 2010
- GPR109A Is a G-protein–Coupled Receptor for the Bacterial Fermentation Product Butyrate and Functions as a Tumor Suppressor in ColonCancer Research, 2009
- Antiatherosclerotic effect of farnesoid X receptorAmerican Journal of Physiology-Heart and Circulatory Physiology, 2009
- Serum Enterolactone Concentration and the Risk of Coronary Heart Disease in a Case-Cohort Study of Finnish Male SmokersAmerican Journal of Epidemiology, 2006
- Bile acids induce energy expenditure by promoting intracellular thyroid hormone activationNature, 2006
- Antibiotic treatment of atherosclerosisCurrent Opinion in Lipidology, 2003